Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial (2021)
Attributed to:
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00461-x
PubMed Identifier: 33676597
Publication URI: http://europepmc.org/abstract/MED/33676597
Type: Journal Article/Review
Parent Publication: The Lancet
Issue: 10279
ISSN: 0140-6736